Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T00938 | ||||
Target Name | DHICA oxidase | ||||
Synonyms | 5,6dihydroxyindole2carboxylic acid oxidase; Catalase B; Glycoprotein 75; Melanoma antigen gp75; TRP; TRP1; Tyrosinaserelated protein 1; TYRP1 | ||||
Target Type | Clinical Trial | ||||
Gene Name | TYRP1 | ||||
Biochemical Class | Tyrosinase | ||||
UniProt ID | TYRP1_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Melanoma | ||||
Example drug | Flanvotumab | Phase 1 | [1], [2] | ||
Tissue | Skin | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.53 Z-score: 0.21 P-value: 7.82E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
![]() |
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
![]() |
|||||
Reference | |||||
REF 1 | ClinicalTrials.gov (NCT01137006) An Open-Label, Dose-Escalation Study of IMC-20D7S In Patients With Malignant Melanoma. U.S. National Institutes of Health. | ||||
REF 2 | NCBI GEO: archive for functional genomics data sets--update. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.